Overview
No overview information available.
Background
No background information available.
Indication
适用于需要非口服途径补充水分或能源及电解质的患者的补液治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Multiple Electrolytes and Invert Sugar Injection | 国药准字H20080720 | 化学药品 | 注射剂 | 5/18/2020 | |
| Multiple Electrolytes and Invert Sugar Injection | 国药准字H20203392 | 化学药品 | 注射剂 | 8/5/2020 | |
| Multiple Electrolytes and Invert Sugar Injection | 国药准字H20203393 | 化学药品 | 注射剂 | 8/5/2020 | |
| Multiple Electrolytes and Invert Sugar Injection | 国药准字H20080721 | 化学药品 | 注射剂 | 5/18/2020 | |
| Multiple Electrolytes and Invert Sugar Injection | 国药准字H20050493 | 化学药品 | 注射剂(注射液) | 3/27/2020 | |
| Multiple Electrolytes and Invert Sugar Injection | 国药准字H20051608 | 化学药品 | 注射剂 | 5/18/2020 | |
| Multiple Electrolytes and Invert Sugar Injection | 国药准字H20050494 | 化学药品 | 注射剂(注射液) | 3/27/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||